Association between early risk factors and CDKN2A/B deletion in pediatric patients with acute lymphoblastic leukemia in a pediatric cancer center in Colombia

Association between early risk factors and CDKN2A/B deletion in pediatric patients with acute lymphoblastic leukemia in a pediatric cancer center in Colombia

Cyclin dependent kinase inhibitor (CDKN) 2A/B deletion is correlated with poor risk factors, such as high blood cell count, higher rate of induction therapy failure, and earlier relapses in pediatric patients with acute lymphoblastic leukemia (ALL). The frequency of CDKN2A/B deletion in the Hispanic...

Full description

Bibliographic Details
Main Authors: Cindy Martinez, Luz Karime Yunis, Edgar Cabrera, Johnny García, Gloria Uribe, Edna Quintero, Juan Jose Yunis, Adriana Linares Ballesteros, Isabel Cristina Sarmiento
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Pediatric Hematology Oncology Journal
Subjects:
Acute lymphoblastic leukemia
MLPA
CDKN2A/B deletion
Pediatrics
Online Access:http://www.sciencedirect.com/science/article/pii/S2468124522000079

Similar Items

Similar Items